Condition: Depression · Cognitive Decline · Sponsor: Indiana University
Depression affects one-third of intensive care unit (ICU) survivors and represents a potentially modifiable target to slow cognitive decline and reduce the risk of Alzheimer's disease and related dementias (ADRD). Our multi-PI team proposes a two-arm RCT called ADEPT-ICU (Attenuating DEPression with Internet CBT to Slow Cognitive Decline in Older ICU Survivors), which will test the efficacy of an internet CBT intervention called Good Days Ahead (GDA) to reduce the burden of subjective cognitive decline (SCD) in older ICU survivors with moderate to severe depressive symptoms after ICU hospitalization.
This description comes directly from the study's public registry record.
Babar Khan, MD, MS · 317-274-9132 · bakhan@iu.edu
Lori Rawlings, RN, BSN · 317-274-9052 · rawlingl@regenstrief.org
Always discuss trial participation with your own doctor first.
| Eskenazi Hospital | Indianapolis, Indiana, United States | Recruiting |
| IU Health Methodist Hospital | Indianapolis, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06627894